Dingding Gao

1200 Cailun Road
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Structure-Based Design and Optimization of Novel PHGDH Inhibitors for Overcoming Erlotinib-Resistant Lung Cancer.

Structure-Based Design and Optimization of Novel PHGDH Inhibitors for Overcoming Erlotinib-Resistant Lung Cancer.

Journal: Journal of medicinal chemistry

Published: June 09, 2026

Design, Synthesis, and Structure-Activity Relationship Studies of Novel 3CLpro Inhibitors.

Design, Synthesis, and Structure-Activity Relationship Studies of Novel 3CLpro Inhibitors.

Journal: ChemMedChem

Published: April 13, 2026

Discovery of novel potent indazole-based FXR agonists via scaffold hopping for MASH treatment.

Discovery of novel potent indazole-based FXR agonists via scaffold hopping for MASH treatment.

Journal: European journal of medicinal chemistry

Published: August 01, 2025

Novel inhibitors of STAT3: an updated patent review (2022-present).

Novel inhibitors of STAT3: an updated patent review (2022-present).

Journal: Expert opinion on therapeutic patents

Published: April 16, 2025

Synthesis and evaluation of novel ebselen derivatives as urease inhibitors for combating Helicobacter pylori infections.

Synthesis and evaluation of novel ebselen derivatives as urease inhibitors for combating Helicobacter pylori infections.

Journal: European journal of medicinal chemistry

Published: January 06, 2025

Mechanistic insights into the dual anti-COVID-19 and anti-inflammatory actions of Zhengqi tablets.

Mechanistic insights into the dual anti-COVID-19 and anti-inflammatory actions of Zhengqi tablets.

Journal: Journal of ethnopharmacology

Published: December 26, 2024

Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines.

Discovery of Novel 4-Hydroxyquinazoline Derivatives: In Silico, In Vivo and In Vitro Studies Using Primary PARPi-Resistant Cell Lines.

Journal: Molecules (Basel, Switzerland)

Published: February 20, 2024

Identification of benzo[b]thiophene-1,1-dioxide derivatives as novel PHGDH covalent inhibitors.

Identification of benzo[b]thiophene-1,1-dioxide derivatives as novel PHGDH covalent inhibitors.

Journal: Bioorganic chemistry

Published: January 01, 2024

Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors.

Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors.

Journal: International journal of biological macromolecules

Published: December 27, 2023

Nature-inspired catalytic asymmetric rearrangement of cyclopropylcarbinyl cation.

Nature-inspired catalytic asymmetric rearrangement of cyclopropylcarbinyl cation.

Journal: Science advances

Published: May 10, 2023

Discovery of highly potent covalent SARS-CoV-2 3CLpro inhibitors bearing 2-sulfoxyl-1,3,4-oxadiazole scaffold for combating COVID-19.

Discovery of highly potent covalent SARS-CoV-2 3CLpro inhibitors bearing 2-sulfoxyl-1,3,4-oxadiazole scaffold for combating COVID-19.

Journal: European journal of medicinal chemistry

Published: March 06, 2023

Discovery of Novel Drug-like PHGDH Inhibitors to Disrupt Serine Biosynthesis for Cancer Therapy.

Discovery of Novel Drug-like PHGDH Inhibitors to Disrupt Serine Biosynthesis for Cancer Therapy.

Journal: Journal of medicinal chemistry

Published: January 03, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026